189 related articles for article (PubMed ID: 11834744)
1. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion.
Ackerman SJ; Liu L; Kwatia MA; Savage MP; Leonidas DD; Swaminathan GJ; Acharya KR
J Biol Chem; 2002 Apr; 277(17):14859-68. PubMed ID: 11834744
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR
Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464
[TBL] [Abstract][Full Text] [Related]
3. Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution.
Swaminathan GJ; Leonidas DD; Savage MP; Ackerman SJ; Acharya KR
Biochemistry; 1999 Oct; 38(42):13837-43. PubMed ID: 10529229
[TBL] [Abstract][Full Text] [Related]
4. The Charcot-Leyden crystal protein revisited-A lysopalmitoylphospholipase and more.
Weller PF; Wang H; Melo RCN
J Leukoc Biol; 2020 Jul; 108(1):105-112. PubMed ID: 32272499
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily.
Ackerman SJ; Corrette SE; Rosenberg HF; Bennett JC; Mastrianni DM; Nicholson-Weller A; Weller PF; Chin DT; Tenen DG
J Immunol; 1993 Jan; 150(2):456-68. PubMed ID: 8419478
[TBL] [Abstract][Full Text] [Related]
6. Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.
Grozdanovic MM; Doyle CB; Liu L; Maybruck BT; Kwatia MA; Thiyagarajan N; Acharya KR; Ackerman SJ
J Allergy Clin Immunol; 2020 Aug; 146(2):377-389.e10. PubMed ID: 31982451
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars.
Dyer KD; Rosenberg HF
Life Sci; 1996; 58(23):2073-82. PubMed ID: 8649192
[TBL] [Abstract][Full Text] [Related]
8. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells.
Zhou Z; Tenen DG; Dvorak AM; Ackerman SJ
J Leukoc Biol; 1992 Dec; 52(6):588-95. PubMed ID: 1464731
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
Dvorak AM; Letourneau L; Login GR; Weller PF; Ackerman SJ
Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
[TBL] [Abstract][Full Text] [Related]
10. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals.
Weller PF; Bach D; Austen KF
J Immunol; 1982 Mar; 128(3):1346-9. PubMed ID: 6173432
[TBL] [Abstract][Full Text] [Related]
11. Combined activities of secretory phospholipases and eosinophil lysophospholipases induce pulmonary surfactant dysfunction by phospholipid hydrolysis.
Kwatia MA; Doyle CB; Cho W; Enhorning G; Ackerman SJ
J Allergy Clin Immunol; 2007 Apr; 119(4):838-47. PubMed ID: 17321580
[TBL] [Abstract][Full Text] [Related]
12. Human eosinophil Charcot-Leyden crystal protein: cloning and characterization of a lysophospholipase gene promoter.
Gomolin HI; Yamaguchi Y; Paulpillai AV; Dvorak LA; Ackerman SJ; Tenen DG
Blood; 1993 Sep; 82(6):1868-74. PubMed ID: 8400237
[TBL] [Abstract][Full Text] [Related]
13. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes.
Dyer KD; Handen JS; Rosenberg HF
Genomics; 1997 Mar; 40(2):217-21. PubMed ID: 9119387
[TBL] [Abstract][Full Text] [Related]
14. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14.
Paul CC; Ackerman SJ; Mahrer S; Tolbert M; Dvorak AM; Baumann MA
J Leukoc Biol; 1994 Jul; 56(1):74-9. PubMed ID: 8027673
[TBL] [Abstract][Full Text] [Related]
15. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.
Dvorak AM; Ackerman SJ
Lab Invest; 1989 Apr; 60(4):557-67. PubMed ID: 2709814
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase).
Weller PF; Bach DS; Austen KF
J Biol Chem; 1984 Dec; 259(24):15100-5. PubMed ID: 6511787
[TBL] [Abstract][Full Text] [Related]
18. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
Weller PF; Goetzl EJ; Austen KF
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258
[TBL] [Abstract][Full Text] [Related]
19. A Brief History of Charcot-Leyden Crystal Protein/Galectin-10 Research.
Su J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30424011
[TBL] [Abstract][Full Text] [Related]
20. Formation of Charcot-Leyden crystals by human basophils.
Ackerman SJ; Weil GJ; Gleich GJ
J Exp Med; 1982 Jun; 155(6):1597-609. PubMed ID: 7042896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
